Gleevec (Imatinib) Price by US State (2026 Analysis)
Estimated Gleevec (Imatinib) retail and out-of-pocket cost (per month supply) across all 50 US states, compared with international pharmaceutical benchmarks in India (approx. $175). US state figures represent modeled healthcare-cost adjustments from the national baseline ($10,000).
Your estimate
Gleevec (Imatinib) cost where you live
Pick your state to see local gleevec (imatinib) pricing
Compared against about $175 per month supply in India.
US figures are modeled from state medical-cost indices, not quotes from named clinics. How we estimate prices.
Every state, side by side
Sort by local price or savings, or filter to jump straight to your state.
51 of 51 states
| India | |||
|---|---|---|---|
| Alabama | $9,000 | $175 | $8,825 (98%) |
| Alaska | $12,800 | $175 | $12,625 (99%) |
| Arizona | $10,000 | $175 | $9,825 (98%) |
| Arkansas | $8,800 | $175 | $8,625 (98%) |
| California | $13,000 | $175 | $12,825 (99%) |
| Colorado | $10,800 | $175 | $10,625 (98%) |
| Connecticut | $12,200 | $175 | $12,025 (99%) |
| Delaware | $10,500 | $175 | $10,325 (98%) |
| Florida | $10,200 | $175 | $10,025 (98%) |
| Georgia | $9,600 | $175 | $9,425 (98%) |
| Hawaii | $13,200 | $175 | $13,025 (99%) |
| Idaho | $9,500 | $175 | $9,325 (98%) |
| Illinois | $10,600 | $175 | $10,425 (98%) |
| Indiana | $9,500 | $175 | $9,325 (98%) |
| Iowa | $9,300 | $175 | $9,125 (98%) |
| Kansas | $9,200 | $175 | $9,025 (98%) |
| Kentucky | $9,000 | $175 | $8,825 (98%) |
| Louisiana | $9,300 | $175 | $9,125 (98%) |
| Maine | $10,600 | $175 | $10,425 (98%) |
| Maryland | $11,800 | $175 | $11,625 (99%) |
| Massachusetts | $12,800 | $175 | $12,625 (99%) |
| Michigan | $9,800 | $175 | $9,625 (98%) |
| Minnesota | $10,600 | $175 | $10,425 (98%) |
| Mississippi | $8,600 | $175 | $8,425 (98%) |
| Missouri | $9,200 | $175 | $9,025 (98%) |
| Montana | $9,800 | $175 | $9,625 (98%) |
| Nebraska | $9,400 | $175 | $9,225 (98%) |
| Nevada | $10,200 | $175 | $10,025 (98%) |
| New Hampshire | $11,200 | $175 | $11,025 (98%) |
| New Jersey | $12,200 | $175 | $12,025 (99%) |
| New Mexico | $9,400 | $175 | $9,225 (98%) |
| New York | $13,000 | $175 | $12,825 (99%) |
| North Carolina | $9,600 | $175 | $9,425 (98%) |
| North Dakota | $9,700 | $175 | $9,525 (98%) |
| Ohio | $9,600 | $175 | $9,425 (98%) |
| Oklahoma | $8,900 | $175 | $8,725 (98%) |
| Oregon | $11,000 | $175 | $10,825 (98%) |
| Pennsylvania | $10,400 | $175 | $10,225 (98%) |
| Rhode Island | $11,400 | $175 | $11,225 (98%) |
| South Carolina | $9,500 | $175 | $9,325 (98%) |
| South Dakota | $9,500 | $175 | $9,325 (98%) |
| Tennessee | $9,200 | $175 | $9,025 (98%) |
| Texas | $10,000 | $175 | $9,825 (98%) |
| Utah | $10,000 | $175 | $9,825 (98%) |
| Vermont | $11,200 | $175 | $11,025 (98%) |
| Virginia | $10,600 | $175 | $10,425 (98%) |
| Washington | $11,800 | $175 | $11,625 (99%) |
| Washington, D.C. | $13,400 | $175 | $13,225 (99%) |
| West Virginia | $9,000 | $175 | $8,825 (98%) |
| Wisconsin | $10,000 | $175 | $9,825 (98%) |
| Wyoming | $9,800 | $175 | $9,625 (98%) |
Frequently Asked Questions: Gleevec (Imatinib) Pricing
Why do Gleevec (Imatinib) prices differ across US states?+
Prescription drug prices in the US vary by state due to differing pharmacy dispensing fee regulations, state tax laws, regional wholesale distribution costs, and varying health insurance plan coverage formularies. Out-of-pocket prices can differ by hundreds of dollars even between neighboring states.
How does the US price of Gleevec (Imatinib) compare to international prices?+
In the United States, Gleevec (Imatinib) averages approximately $10,000 per month supply. In India, certified manufacturers produce equivalent formulations and authorized generics for about $175 per month supply — saving patients up to 90%+ without compromising therapeutic equivalence.
Are generic or biosimilar versions of Gleevec (Imatinib) available?+
Yes, the active pharmaceutical ingredient is Imatinib. In many overseas markets like India, approved generics manufactured in WHO-GMP compliant facilities are widely dispensed at a fraction of US brand name costs.
Other Cancer Medications
Keytruda (Pembrolizumab)
Keytruda (pembrolizumab) is an immunotherapy (a PD-1 checkpoint inhibitor) delivered by IV infusion that helps the immune system recognize and attack many cancers, including melanoma, lung, and head-and-neck cancers. Each dose in the USA costs many thousands of dollars and treatment runs for months. The same infusions are administered in Indian oncology centers at a substantially lower per-dose price.
Revlimid (Lenalidomide)
Revlimid (lenalidomide) is an oral targeted therapy used to treat multiple myeloma, myelodysplastic syndromes, and certain lymphomas, often taken in monthly cycles. Its US cost is among the highest of any oral cancer drug. Generic lenalidomide manufactured in India reduces the monthly cost by well over 95%.